Cargando…
Lysophosphatidic Acid Pretreatment Attenuates Myocardial Ischemia/Reperfusion Injury in the Immature Hearts of Rats
The cardioprotection of the immature heart during cardiac surgery remains controversial due to the differences between the adult heart and the newborn heart. Lysophosphatidic acid (LPA) is a small bioactive molecule with diverse functions including cell proliferation and survival via its receptor: L...
Autores principales: | Chen, Haibo, Liu, Si, Liu, Xuewen, Yang, Jinjing, Wang, Fang, Cong, Xiangfeng, Chen, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359218/ https://www.ncbi.nlm.nih.gov/pubmed/28377726 http://dx.doi.org/10.3389/fphys.2017.00153 |
Ejemplares similares
-
Febuxostat pretreatment attenuates myocardial ischemia/reperfusion injury via mitochondrial apoptosis
por: Wang, Shulin, et al.
Publicado: (2015) -
Lysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-κB Dependent Matrix Metalloproteinase-9 Expression via LPA(2) in Macrophages
por: Gu, Chun, et al.
Publicado: (2017) -
Amifostine Pretreatment Attenuates Myocardial Ischemia/Reperfusion Injury by Inhibiting Apoptosis and Oxidative Stress
por: Wu, Shao-ze, et al.
Publicado: (2017) -
Protective Role for LPA(3) in Cardiac Hypertrophy Induced by Myocardial Infarction but Not by Isoproterenol
por: Cai, Lin, et al.
Publicado: (2017) -
Protective Mechanisms of Quercetin Against Myocardial Ischemia Reperfusion Injury
por: Zhang, Yu-Min, et al.
Publicado: (2020)